This document presents information on recombinant vaccines. It begins by listing WHO's top disease priorities and providing brief histories of pandemics. It then discusses traditional vaccine limitations and introduces recombinant vaccines as a safer and more effective alternative. The document explains the production of subunit, DNA, conjugate, and edible recombinant vaccines. It highlights DNA vaccines' ability to induce both humoral and cellular immunity through prolonged antigen expression. In closing, it notes recombinant vaccines currently in development and trials for diseases like cancer, malaria, and Ebola.